[SY17] シンポジウム17（Clinical, Basic）
ホルモンと癌

[SY17-3] Lymphangioleiomyomatosis (LAM): The “Other” Steroid-Sensitive Cancer

^○Stephen R. Hammes (Division of Endocrinology, Department of Medicine, University of Rochester Medical Center, Rochester, NY USA)

Dr. Hammes graduated with a degree in Chemistry from Cornell University in 1985. He completed his M.D. as well as his Ph.D. in Microbiology and Immunology from Duke University in 1993. Dr. Hammes then moved to the University of California in San Francisco (UCSF), where he completed an internship and residency in General Medicine, followed by a fellowship in Endocrinology.
In 1999, Dr. Hammes joined the faculty at the University of Texas Southwestern Medical Center in Dallas, where he was a W.W. Caruth Scholar in Biomedical Research and Co-Director of the Endocrinology Fellowship program. Dr. Hammes moved to the University of Rochester in 2009 to become the Louis S. Wolk Distinguished Professor of Medicine and the Chief of the Division of Endocrinology, Diabetes, and Metabolism. He is also the Associate Chair for Academic Affairs within the Department of Medicine at the University of Rochester.
Dr. Hammes has served as Editor-in-Chief of the scientific journals “Molecular Endocrinology” and “Endocrinology.” He is a member of the American Society for Clinical Investigation, and actively serves on N.I.H. and D.O.D. study sections.